On the other hand, because ATM can stimulate the differentiation of myofibroblastic cancer-associated fibroblasts, which promote suppressive TIME, ATM inhibition in fibroblasts can increase tumor-infiltrating CD8+ T cells and improve ICB therapy in mouse models of lung and colon cancers [37]. The gene discussed is CD8A; the disease is neoplasm.